Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.

Volume: 114, Issue: 41, Pages: 201701821
Published: Oct 10, 2017
Abstract
The molecular underpinnings of invasion, a hallmark of cancer, have been defined in terms of individual mediators but crucial interactions between these mediators remain undefined. In xenograft models and patient specimens, we identified a c-Met/β1 integrin complex that formed during significant invasive oncologic processes: breast cancer metastases and glioblastoma invasive resistance to antiangiogenic VEGF neutralizing antibody, bevacizumab....
Paper Details
Title
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
Published Date
Oct 10, 2017
Volume
114
Issue
41
Pages
201701821
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.